192 related articles for article (PubMed ID: 33660254)
1. Melanoma-associated glycosyltransferase GCNT2 as an emerging biomarker and therapeutic target.
Perez M; Chakraborty A; Lau LS; Mohammed NBB; Dimitroff CJ
Br J Dermatol; 2021 Aug; 185(2):294-301. PubMed ID: 33660254
[TBL] [Abstract][Full Text] [Related]
2. Loss of GCNT2/I-branched glycans enhances melanoma growth and survival.
Sweeney JG; Liang J; Antonopoulos A; Giovannone N; Kang S; Mondala TS; Head SR; King SL; Tani Y; Brackett D; Dell A; Murphy GF; Haslam SM; Widlund HR; Dimitroff CJ
Nat Commun; 2018 Aug; 9(1):3368. PubMed ID: 30135430
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of N-acetylglucosaminyltransferases III and V in human melanoma cells. Implications for MCAM N-glycosylation.
Bubka M; Link-Lenczowski P; Janik M; Pocheć E; Lityńska A
Biochimie; 2014 Aug; 103():37-49. PubMed ID: 24726881
[TBL] [Abstract][Full Text] [Related]
4. N-linked polylactosamine glycan synthesis is regulated by co-expression of β3GnT2 and GCNT2.
Henion TR; Schwarting GA
J Cell Physiol; 2014 Apr; 229(4):471-8. PubMed ID: 24105809
[TBL] [Abstract][Full Text] [Related]
5. Engagement of I-branching {beta}-1, 6-N-acetylglucosaminyltransferase 2 in breast cancer metastasis and TGF-{beta} signaling.
Zhang H; Meng F; Wu S; Kreike B; Sethi S; Chen W; Miller FR; Wu G
Cancer Res; 2011 Jul; 71(14):4846-56. PubMed ID: 21750175
[TBL] [Abstract][Full Text] [Related]
6. I-branched carbohydrates as emerging effectors of malignant progression.
Dimitroff CJ
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):13729-13737. PubMed ID: 31213534
[TBL] [Abstract][Full Text] [Related]
7. GCNT2 induces epithelial-mesenchymal transition and promotes migration and invasion in esophageal squamous cell carcinoma cells.
Peng F; He Q; Cheng C; Pan J
Cell Biochem Funct; 2019 Jan; 37(1):42-51. PubMed ID: 30575058
[TBL] [Abstract][Full Text] [Related]
8. Hypoxia Controls the Glycome Signature and Galectin-8-Ligand Axis to Promote Protumorigenic Properties of Metastatic Melanoma.
Chakraborty A; Perez M; Carroll JD; Antonopoulos A; Dell A; Ortega L; Mohammed NBB; Wells M; Staudinger C; Griswold A; Chandler KB; Marrero C; Jimenez R; Tani Y; Wilmott JS; Thompson JF; Wang W; Sackstein R; Scolyer RA; Murphy GF; Haslam SM; Dimitroff CJ
J Invest Dermatol; 2023 Mar; 143(3):456-469.e8. PubMed ID: 36174713
[TBL] [Abstract][Full Text] [Related]
9. Case report of homozygous deletion involving the first coding exons of GCNT2 isoforms A and B and part of the upstream region of TFAP2A in congenital cataract.
Happ H; Weh E; Costakos D; Reis LM; Semina EV
BMC Med Genet; 2016 Sep; 17(1):64. PubMed ID: 27609212
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of miR-199a/b-5p is associated with GCNT2 induction upon epithelial-mesenchymal transition in colon cancer.
Chao CC; Wu PH; Huang HC; Chung HY; Chou YC; Cai BH; Kannagi R
FEBS Lett; 2017 Jul; 591(13):1902-1917. PubMed ID: 28542779
[TBL] [Abstract][Full Text] [Related]
11. Diverse expression of N-acetylglucosaminyltransferase V and complex-type β1,6-branched N-glycans in uveal and cutaneous melanoma cells.
Pocheć E; Rydlewska M; Przybyło M; Lityńska A
Acta Biochim Pol; 2015; 62(2):323-8. PubMed ID: 26098720
[TBL] [Abstract][Full Text] [Related]
12. I-branching N-acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling.
Mikami J; Tobisawa Y; Yoneyama T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Ohyama C; Fukuda M
Cancer Sci; 2016 Mar; 107(3):359-68. PubMed ID: 26678556
[TBL] [Abstract][Full Text] [Related]
13. Effect of N-acetylglucosaminyltransferase V on the expressions of other glycosyltransferases.
Guo P; Zhang Y; Shen ZH; Zhang XY; Chen HL
FEBS Lett; 2004 Mar; 562(1-3):93-8. PubMed ID: 15044007
[TBL] [Abstract][Full Text] [Related]
14. A glycomic approach to the identification and characterization of glycoprotein function in cells transfected with glycosyltransferase genes.
Taniguchi N; Ekuni A; Ko JH; Miyoshi E; Ikeda Y; Ihara Y; Nishikawa A; Honke K; Takahashi M
Proteomics; 2001 Feb; 1(2):239-47. PubMed ID: 11680870
[TBL] [Abstract][Full Text] [Related]
15. The relationship between the branch-forming glycosyltransferases and cell surface sugar chain structures.
Takamatsu S; Inoue N; Katsumata T; Nakamura K; Fujibayashi Y; Takeuchi M
Biochemistry; 2005 Apr; 44(16):6343-9. PubMed ID: 15835923
[TBL] [Abstract][Full Text] [Related]
16. Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V.
Lee JK; Matthews RT; Lim JM; Swanier K; Wells L; Pierce JM
J Biol Chem; 2012 Aug; 287(34):28526-36. PubMed ID: 22715095
[TBL] [Abstract][Full Text] [Related]
17. How glycosylation affects glycosylation: the role of N-glycans in glycosyltransferase activity.
Mikolajczyk K; Kaczmarek R; Czerwinski M
Glycobiology; 2020 Dec; 30(12):941-969. PubMed ID: 32363402
[TBL] [Abstract][Full Text] [Related]
18. Glycans and cancer: role of N-glycans in cancer biomarker, progression and metastasis, and therapeutics.
Taniguchi N; Kizuka Y
Adv Cancer Res; 2015; 126():11-51. PubMed ID: 25727145
[TBL] [Abstract][Full Text] [Related]
19. Expression of fucosyltransferases contributes to melanoma invasive phenotype.
Ciołczyk-Wierzbicka D; Bodzioch M; Gil D; Zmudzińska D; Dembińska-Kieć A; Laidler P
Med Chem; 2007 Sep; 3(5):418-24. PubMed ID: 17897065
[TBL] [Abstract][Full Text] [Related]
20. Aberrant methylation of GCNT2 is tightly related to lymph node metastasis of primary CRC.
Nakamura K; Yamashita K; Sawaki H; Waraya M; Katoh H; Nakayama N; Kawamata H; Nishimiya H; Ema A; Narimatsu H; Watanabe M
Anticancer Res; 2015 Mar; 35(3):1411-21. PubMed ID: 25750292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
